Gene targeting in stem cells from individuals with osteogenesis imperfecta.
D000483:Alleles; D000818:Animals; D001854:Bone Marrow Cells / Q000502:physiology; D002454:Cell Differentiation; D002478:Cells, Cultured; D024042:Collagen Type I / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D000229:Dependovirus / Q000235:genetics; D018390:Gene Targeting; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D019868:Kanamycin Kinase / Q000235:genetics; D008297:Male; D059630:Mesenchymal Stem Cells / Q000502:physiology*; D051379:Mice; D010012:Osteogenesis; D010013:Osteogenesis Imperfecta / Q000235:genetics* / Q000628:therapy*; D017354:Point Mutation; D011995:Recombination, Genetic; D033581:Stem Cell Transplantation
D024042:Collagen Type I; D019868:Kanamycin Kinase